ADDISON, TEXAS (June 2023): StrideCare, a multi-specialty physician group focused on delivering comprehensive lower extremity care, is excited to announce its acquisition of the Texas Center for Interventional Surgery (TCIS), a medical facility specializing in minimally invasive interventional procedures. This strategic move marks another significant milestone in StrideCare’s expansion plans, further solidifying its position as a value-based provider in the Texas medical community.
Previously a part of Texas Oncology, TCIS and its specialists have earned a well-deserved reputation in delivering high-quality, minimally invasive cancer procedures. StrideCare will continue that tradition while expanding to offer an even greater comprehensive range of innovative oncological solutions which will improve the quality of care available to cancer patients. This expansion reinforces StrideCare’s commitment to transforming healthcare and addressing the critical needs of patients.
TCIS has established itself as a trusted provider of interventional surgery services, while specializing in minimally invasive procedures and cutting-edge treatments. With a team of highly skilled physicians and a state-of-the-art facility, TCIS has earned a strong reputation in North Texas for delivering exceptional outcomes and compassionate patient care. The acquisition of TCIS aligns perfectly with StrideCare’s mission of enhancing patient care by offering advanced interventional services in the North Texas region. The TCIS integration strengthens StrideCare’s commitment to high-quality value-based care with improved outcomes.
Patients will gain access to an even broader range of interventional procedures and specialists, therefore benefiting from enhanced treatment options and improved care pathways. Additionally, leading healthcare professionals in the community will have the opportunity to bring their patients to this state-of-the-art facility.
“This strategic move allows us to enter the oncology space and further our mission of transforming healthcare,” said Jaryd Stein, MD, Chief Medical Officer at StrideCare. “Through this acquisition, we not only expand our capabilities in interventional surgery but also strengthen our ability to partner with physicians in the community. By working together, we can offer cost-effective solutions that prioritize the well-being of our patients, while driving positive outcomes in a more accessible and affordable manner.”
Building North Texas
Under new ownership, TCIS will continue its operations without disruption, ensuring a seamless transition of the exceptional care patients have come to expect. StrideCare will leverage its technological capabilities and resources to augment TCIS’s service offerings and streamline operational efficiencies.
“We are thrilled to welcome Texas Center for Interventional Surgery into the StrideCare family,” said Al Wilson, President and COO at StrideCare. “This acquisition represents an exciting opportunity for us to further our mission of delivering cutting-edge healthcare services to patients. We are confident that the integration of TCIS into our platform will not only strengthen our service offerings but also enhance the overall patient experience.”
StrideCare is a multi-specialty physician group focused on improving patient lives by offering value based comprehensive lower extremity care. StrideCare’s expert providers specialize in the treatment of foot and ankle conditions, wound care, and vascular disease consisting of both arterial and venous conditions. StrideCare helps patients achieve improved quality of life and prevents limb loss from both common and complex conditions including diabetic vascular issues, peripheral arterial disease, venous insufficiency, foot neuropathy, varicose veins, diabetic foot ulcers, and wounds. Learn more about StrideCare at StrideCare.com or by calling (469) 850-5760.